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Molecular and Cellular Mechanisms Review
of Cardiac Arrhythmias
then slowly repolarize, which is denoted as the T wave
on the ECG, leading to cardiac relaxation and comple-
tion of one cardiac cycle.
Mark T. Keating*‡ and Michael C. Sanguinetti†‡
*Howard Hughes Medical Institute
Department of Cell Biology
Harvard Medical School The rhythmic activity of the human heart is clearly
apparent by ultrasound after only five weeks of gesta-Department of Cardiology
Children’s Hospital tion. It is remarkable to think how flawlessly the heart
performs in the course of one’s life, beating z70 timesBoston, Massachusetts 02115
†Department of Medicine per minute over a course of 75 to 90 years. One’s heart
must beat, therefore, z36 million times a year, a remark-Division of Cardiology
Eccles Program in Human Molecular Biology able feat considering that there is virtually no tolerance
for failure.and Genetics
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Salt Lake City, Utah 84112 Cardiac Arrhythmias and Sudden Death
Although most hearts beat with remarkable fidelity and
resilience, under certain circumstances the rhythm of
the heart can fail. This is known as a cardiac arrhythmia.Introduction
When the heartbeat is too slow (bradyarrhythmia orThe heart is a pump (Figure 1). Through coordinated
bradycardia) blood pressure cannot be maintained,contraction of the atria, blood is pumped into the ventri-
leading to loss of consciousness and death. Bradyar-cles. The ventricles, which do most of the work of the
rhythmias often result from disease or death of pace-heart, contract synchronously to pump blood to the rest
maker and other specialized conducting cells and canof the body. The right ventricle pumps deoxygenated
be effectively treated with artificial, electronic pacemak-blood to the lungs for gas exchange. The left ventricle,
ers. Similarly, if the heart rhythm is too rapid (tachyar-the most forceful chamber of the heart, pumps blood
rhythmia or tachycardia), blood pressure cannot beto the rest of the organs, including the brain, kidneys,
maintained, leading to syncope and sudden death. Theliver, skeletal muscle, and other vital organs. Through
most dangerous tachyarrhythmias are focused in thethis pumping action, the left ventricle maintains sys-
ventricles and are known as ventricular tachycardia, tor-temic blood pressure at approximately 120 over 80 milli-
sades de pointes ventricular tachycardia, and ventricu-meters of mercury. The brain is particularly sensitive to
lar fibrillation (Figure 1). Torsades de pointes meansblood pressure and flow. If the coordinated contraction
twisting around the point, an allusion to the alternatingof ventricles is stopped for only a few seconds, blood
axis of the QRS complex around the isoelectric line of thepressure drops and consciousness is lost. This sudden
ECG during this arrhythmia (Lazzara, 1997) (Figure 1).loss of consciousness is called syncope. If the mechani-
Cardiac arrhythmias are a leading cause of morbiditycal activity of the heart is lost for more than a few min-
and mortality. More than 300,000 individuals in theutes, permanent brain damage and death ensue.
United States die suddenly every year, and in mostThe mechanical activity of the heart is controlled by
cases it is assumed that the underlying cause of suddenelectrical impulses (Figure 1). These impulses are intrin-
death is ventricular tachyarrhythmia (Kannel et al., 1987;sic to the heart but are also modulated by neuronal
Willich et al., 1987). Despite their importance, until re-activity through the autonomic nervous system. Special-
cently the understanding of the molecular mechanismsized cells in the right atrium known as the sino-atrial
underlying life-threatening ventricular tachyarrhythmiasnode act as the pacemaker, spontaneously firing z70
was poor. The ability to predict, prevent, and treat thesetimes per minute at rest and up to about 200 times
disorders remains a major scientific and medical chal-per minute during rigorous exercise. This impulse is
lenge.conveyed to all atrial myocytes, leading to coordinated
An example of an individual with cardiac arrhythmiadepolarization and contraction of the atria. On a surface
may provide insight into these disorders (Splawski etelectrocardiogram (ECG) atrial depolarization can be
al., 1997a). A 25-year-old woman was seen for routinevisualized as a P wave. The electrical activity of the
evaluation by her obstetrician. She was healthy and inpacemaker is also conveyed to specialized cells that
her 35th week of gestation in an apparently uncompli-connect the atria and the ventricles, known as the atrio-
cated pregnancy. During examination the physicianventricular node. Here, the electrical activity is delayed
noted a bradyarrhythmia in the fetus. The fetus’s heartfor about 20 milliseconds, giving the atria time to pump
rate was only 70–80 beats per minute, approximatelyblood into the ventricles. Then, the electrical activity
half the normal rate. Ultrasonic examination, however,is conveyed to specialized fibers known as bundle
revealed normal fetal development, and the pregnancybranches, leading to rapid depolarization of all ventricu-
was allowed to come to term. The child was born withoutlar myocytes and coordinated contraction of the ventri-
complication at 39 weeks gestation.cles. Depolarization of the ventricles can be visualized
During the first feeding, the child experienced distresson the ECG as the QRS complex. Ventricular myocytes
and turned blue. She was rushed to the neonatal inten-
sive care unit, where a series of tests were performed.
‡ E-mail: mkeating@genetics.med.harvard.edu All of these tests were normal except for the ECG, which
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(Moss, 1995) (Figure 1). It can be associated with syn-
cope and sudden death due to episodic cardiac arrhyth-
mias, particularly torsades de pointes ventricular tachy-
cardia and ventricular fibrillation (Vincent et al., 1992;
Schwartz et al., 1993). Most individuals with long QT
syndrome have no other symptoms or signs of disease,
and arrhythmias are relatively rare except in severe
cases. As noted above, however, some cases of long
QT syndrome are associated with congenital deafness
and this disorder has also been associated with syndac-
tyly, an abnormal webbing of fingers or toes (Marks et
al., 1995).
The long QT syndromes can be divided on clinical
grounds into two main types: familial and acquired.
There are at least two familial forms of long QT syn-
drome. One, which was described above, was believed
to be inherited as an autosomal recessive trait and asso-
ciated with congenital deafness, the Jervell and Lange-
Nielsen syndrome (Jervell and Lange-Nielsen, 1957). A
second, more common familial form is inherited as an
autosomal dominant trait with no other phenotypic ab-
normalities. This form, which is sometimes referred to
Figure 1. The Heart Is an Electrically Activated Pump as the Romano Ward syndrome (Romano et al., 1963;
(A) A schematic representation of a four-chambered heart including Ward, 1964), is usually associated with less arrhythmia
specialized cells that act as a pacemaker (the sino-atrial node, SAN) risk than the autosomal recessive form. The most com-
and conducting tissues such as the atrio-ventricular node (AVN) and
mon form of long QT syndrome is acquired. There arethe right and left bundle branches (RBB, LBB). RA 5 right atrium;
many different causes of acquired long QT syndrome,LA 5 left atrium; RV 5 right ventricle; LV 5 left ventricle. (B) Normal
electrocardiogram (ECG) and an ECG showing QT interval prolonga- including heart diseases such as cardiomyopathy and
tion. Note that voltage is on the Y axis and time is on the X axis. The cardiac ischemia, bradycardia, and metabolic abnor-
P wave represents atrial depolarization, QRS complex represents malities like reduced serum potassium concentration
ventricular depolarization and the T wave represents ventricular (Roden et al., 1996). Treatment with many medications,
repolarization. A normal QTc interval is z0.40 s. QTc interval prolon-
including certain antibiotics, antihistamines, and antiar-gation results from abnormal cardiac repolarization. (C) ECG show-
rhythmics is the most common cause of acquired longing normal sinus rhythm converting to torsades de pointes ventricu-
lar tachycardia and ventricular fibrillation, a life-threatening cardiac QT syndrome (Roden, 1998).
arrhythmia. When molecular studies of long QT syndrome were
initiated, there were two main theories invoked to explain
the pathogenesis of this disorder. One was the autonomicshowed bradycardia with a heart rate of 82 beats per
imbalance hypothesis. This theory was based on studiesminute and a prolonged QTc interval of z0.60 s. The
showing that manipulation of the autonomic nervousrate-corrected QT (QTc) interval is a temporal measure
system in dogs could lead to QT prolongation and car-of ventricular repolarization and is normally about 0.40
diac arrhythmias (Abildskov, 1991). A second hypothe-s. Because of these findings, a pediatric cardiologist
sis, the cardiac ion channel hypothesis, suggested thatwas consulted, who ordered audiographic evaluation.
inherited or acquired dysfunction of cardiac ion chan-These tests showed severe bilateral hearing loss and a
nels could lead to this disorder. While it is clear that thetentative diagnosis of Jervell and Lange-Nielsen syn-
autonomic nervous system plays a secondary role indrome was made. This disorder, a form of long QT syn-
many cardiac arrhythmias, the cardiac ion channel hy-drome, is a familial cardiac arrhythmia associated with
pothesis has proved to be the primary mechanism ofcongenital deafness. It was previously believed to be
arrhythmia susceptibility in studies reported to dateinherited as an autosomal recessive trait. The child was
(Figure 2).placed on beta-blockers, drugs that reduce the auto-
nomic nervous activity of the heart, and observed for
several days without complication. She was sent home Mutations in Cardiac Ion Channel Genes Cause
Arrhythmia Susceptibilityafter 10 days with a monitor. Because Jervell and Lange-
Nielsen syndrome was thought to be purely recessive, To define genes that contribute to arrhythmia suscep-
tibility, familial forms of this disorder were examined,no clinical evaluation of the child’s parents or other
family members was performed. Several months after particularly long QT syndrome. Over the last six years,
six arrhythmia susceptibility genes were discovered:the birth of the child, her overstressed mother was awak-
ened by an alarm clock, stood up, had a cardiac arrest, KVLQT1, HERG, SCN5A, minK, MiRP1, RyR2 (Table 1)
(Curran et al., 1995; Wang et al., 1995a, 1995b, 1996;and died. She had previously enjoyed excellent health,
and had no history of syncope. Splawski et al., 1997a, 1997b; Chen et al., 1998; Abbott
et al., 1999; Priori et al., 2000). KVLQT1 was discovered
using positional cloning. HERG, SCN5A, and RyR2 wereLong QT Syndrome, a Familial Cardiac Arrhythmia
Long QT syndrome is a group of disorders that is usually identified using the positional cloning–candidate gene
approach, and minK and MiRP1 were discovered using acharacterized by a prolonged QT interval on the ECG
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and Lange-Nielsen syndrome was previously believed
to be an autosomal recessive disorder. Phenotypic eval-
uation of this family, however, revealed a more compli-
cated picture (Splawski et al., 1997a). Many members
of the family, including the proband’s father, had subtle
prolongation of the QT interval with normal hearing.
Some individuals gave a history of one or two syncopal
episodes, but no cases of sudden death were noted.
Furthermore, pedigree analyses revealed that the pro-
band resulted from a consanguineous marriage in that
her parents were second cousins. This led to the hypoth-
esis that homozygous mutations of an autosomal domi-
nant long QT syndrome gene might cause Jervell and
Lange-Nielsen syndrome. This proved to be the case,
and it is now clear that homozygous mutations of either
KVLQT1 or minK can cause this disorder (Neyroud et
al., 1997; Splawski et al., 1997b; Duggal et al., 1998).
The molecular genetics also helped to define the clinical
picture. One aspect of Jervell and Lange-Nielsen syn-
drome, congenital deafness, is inherited as an autoso-
mal recessive trait in that heterozygous carriers have
no obvious hearing deficit. However, arrhythmia suscep-
tibility is inherited as a semidominant trait. That is, het-
erozygotes and homozygotes both have arrhythmia sus-
ceptibility, but the risk of arrhythmia in homozygotes is
much greater. Homozygous mutations of HERG have
also been reported (Hoorntje et al., 1999). This condition
also causes severe arrhythmia susceptibility, but is not
associated with other phenotypic abnormalities.
Autosomal dominant long QT syndrome genes became
candidates for involvement in other familial arrhythmia
susceptibility syndromes. Although the familial occur-
rence of virtually every arrhythmia has been reported, in
most cases, the mode of inheritance is unclear. Familial
ventricular fibrillation, by contrast, can be inherited as a
clear, autosomal dominant trait. As in long QT syndrome,
people with familial ventricular fibrillation often appear
healthy (Martini, 1989). Electrocardiographic evaluation
of these individuals shows no evidence of QT interval
prolongation. In some cases, subtle prolongation of the
QRS complex can be demonstrated. A distinct electro-
cardiographic feature of elevation of the ST segment
has been described in some individuals and referred to
as the Brugada syndrome (Brugada et al., 1997). Some
forms of familial ventricular fibrillation have also been
associated with conduction abnormalities. In all cases,
Figure 2. Ion Channel Mutations Cause Cardiac Arrhythmias these individuals are at increased risk for episodic ven-
Schematic representation of ion channels encoded by arrhythmia tricular fibrillation, a particularly lethal arrhythmia. When
susceptibility genes including KVLQT1 potassium channel a sub- ventricular fibrillation occurs, there is no cardiac output,
units, HERG potassium channel a subunits, SCN5A sodium channel and permanent brain damage and death ensue unless
a subunits, minK potassium channel b subunits, MiRP1 potassium
the arrhythmia is controlled. As noted above, SCN5Achannel b subunits, and RyR2 ryanodine receptor/calcium release
mutations can cause arrhythmia susceptibility in certainchannel. Missense mutations are indicated by red dots, and the
familial forms of long QT syndrome (Table 1). Recentlocation of frameshifts or intragenic deletions are indicated by
blue dots. molecular genetic studies have demonstrated that
SCN5A mutations can also cause familial ventricular
fibrillation (Chen et al., 1998). Thus, SCN5A mutations
candidate gene approach. A seventh long QT syndrome can cause several different forms of arrhythmia suscep-
locus was mapped to chromosome 4, but this gene has tibility.
not yet been identified (Schott et al., 1995). Additional The genetic basis for a third familial cardiac arrhyth-
locus heterogeneity was described and several addi- mia, catecholaminergic ventricular tachycardia, has re-
tional arrhythmia genes await discovery (Jiang et al., cently become apparent. This disorder is characterized
1994). These studies provided the first molecular insight by syncope and sudden death in otherwise healthy
into the pathogenesis of cardiac arrhythmias. young individuals due to episodic ventricular tachycar-
dia. Recent studies demonstrate that this disorder isAs noted in the case report described above, Jervell
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Table 1. Molecular and Cellular Mechanisms of Cardiac Arrhythmias
Diseasea Inheritance Geneb (alternate name) Protein Mechanism
LQT autosomal dominant KVLQT1 (KCNQ1) IKsK1 channel a subunit repolarization abnormality
HERG (KCNH2) IKrK1 channel a subunit repolarization abnormality
SCN5A INaK1 channel a subunit repolarization abnormality
LQT4 ? ?
minK (KCNE1) IKsK1 channel b subunit repolarization abnormality
MiRP1 (KCNE2) IKrK1 channel b subunit repolarization abnormality
LQT7 ? ?
autosomal recessive KVLQT1 IKsK1 channel a subunit repolarization abnormality
(with deafness)
minK IKsK1 channel b subunit repolarization abnormality
syndactyly associated ? ? ?
acquired (drug induced) HERG IKrK1 channel a subunit repolarization abnormality
MiRP1 IKrK1 channel b subunit repolarization abnormality
IVF autosomal dominant SCN5A INaNa1 channel a subunit conduction abnormality
IVF2 ? ?
CVT autosomal dominant RyR2 Ryanodine receptor/ calcium overload
Ca21 release channel
a LQT 5 long QT syndrome; IVF 5 familial idiopathic ventricular fibrillation; CVT 5 catecholaminergic ventricular tachycardia.
b LQT4, LQT7, IVF2: genes not identified.
caused by mutations in RyR2, the ryanodine receptor L-type calcium channels and gradually increasing out-
ward current through several types of potassium chan-gene (Priori et al., 2000).
In summary, the genetic basis of arrhythmia suscepti- nels. The total amount of current during the plateau
phase of the cardiac action potential is small. As a con-bility has begun to emerge. Six arrhythmia genes have
been identified to date: SCN5A, KVLQT1, minK, HERG, sequence, relatively small changes in ion current during
this phase can have a major impact on action potentialMiRP1, RyR2. SCN5A mutations can cause both long QT
syndrome and familial ventricular fibrillation. KVLQT1, duration. At this point in the cardiac cycle the ECG has
returned to baseline. Phase 3 represents myocellularminK, HERG, and MiRP1 mutations have been impli-
cated in long QT syndrome. RyR2 mutations cause cate- repolarization, an effect mediated by outward potassium
currents. Physiologic and pharmacologic studies havecholaminergic ventricular tachycardia. In general, ar-
rhythmia susceptibility is more severe in homozygotes defined two main repolarizing potassium currents, IKr
and IKs, that sum to terminate the plateau phase andthan in heterozygotes. Although some familial forms of
arrhythmia susceptibility are associated with additional initiate final repolarization (Sanguinetti and Jurkiewicz,
1990). Other currents such as the plateau delayed recti-obvious phenotypic abnormalities (e.g., congenital neu-
ral deafness in Jervell and Lange-Nielsen syndrome), fier K1 current (IKp) and the inward rectifier K1 current
(IK1) also contribute to repolarization. IKr is the rapidlymost of these individuals appear grossly normal and go
undetected until their first arrhythmia strikes. activating delayed rectifier potassium current that is
specifically blocked by methanesulfonanilide drugs.
When IKr current is blocked by these drugs, IKs, the slowlyIon Channels and the Cardiac Action Potential
Like other excitable cells, including neurons, skeletal activating delayed rectifier potassium current, remains.
The repolarization phase correlates with the T wave onmuscle, and smooth muscle, cardiac myocyte excitabil-
ity results from action potentials. The cardiac myocyte surface ECG. Phase 4 is the final phase of the action
potential and signals a return of membrane potential toaction potential, however, is distinctive in its duration,
which is much longer at z300 ms. By contrast, the action its baseline near 285 mV. This phase represents ventric-
ular relaxation or diastole and is indicated on the ECGpotentials of neurons and skeletal muscle last a few
milliseconds. The cardiac action potential consists of as a return to baseline. Thus, the coordinated opening
and closing of ion channels mediates the cardiac actionfive phases, numbered 0–4 (Figure 3). Phase 0 repre-
sents depolarization of the myocyte. This phase is initi- potential. Duration of the QT interval on surface ECG is
related to the length of ventricular action potentials.ated by the rapid opening (activation) of voltage-gated
sodium channels. Depolarization of all ventricular myo-
cytes is measurable as the QRS complex on the surface Sodium Channel Dysfunction Can Cause Several
Different Types of ArrhythmiaECG. Phase 1 of the cardiac action potential occurs
immediately after the peak of depolarization and is rec- Investigators had previously demonstrated that SCN5A
encodes the a subunits of sodium channels that areognized as a partial repolarization of the membrane.
This small repolarizing effect is due to the closure (inacti- responsible for initiating cardiac action potentials (Gel-
lens et al., 1992). This gene is located on chromosomevation) of cardiac sodium channels, and activation of
transient outward potassium current. Phase 2 of the 3p21-p24 and encodes a protein with a predicted topol-
ogy of four major domains, DI through DIV (Figure 2).action potential is the plateau phase. The relatively long
duration of this phase is unique to ventricular and Pur- Each of these domains is believed to have a structure
similar to a voltage-gated potassium channel with sixkinje fiber myocytes. The plateau is generated primarily
by slowly decreasing inward calcium currents through membrane-spanning domains (S1–S6) and pore do-
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logic consequences. Theoretically, reduction of sodium
current would be expected to slightly shorten action
potential duration and slow conduction velocity. It is
also not yet clear exactly how reduction in the total
number of functional sodium channels and expression
of a heterogeneous population of sodium channels lead
to arrhythmia. Clues may come from pharmacologic
studies, which show that inhibition of sodium channel
current can cause heterogeneity in action potential con-
figuration in the right ventricular epicardium, leading toFigure 3. The Cardiac Action Potential Is Mediated by Ion Currents
marked dispersion of repolarization and refractorinessSchematic representation of a cardiac action potential with voltage
(Krishnan and Antzelevitch, 1991). This creates a sub-on the Y axis and time on the X axis. Note that the cardiac action
potential duration is quite long, for example, 200 milliseconds for strate for the development of reentrant arrhythmias.
the ventricular myocyte shown here. Inward sodium current medi- Some familial ventricular fibrillation mutations of SCN5A
ates the rapid phase 0 depolarization. Transient outward K1 currents may cause an abnormality of conduction, and in some
(Ito) mediate rapid phase 1 repolarization. The L-type inward calcium cases, baseline electrocardiograms in affected individu-current contributes to the long plateau duration (phase 2). Many
als show conduction abnormalities. In summary, bothoutward potassium currents are responsible for repolarization of
gain- and loss-of-function mutations of SCN5A canthe cardiac action potential (phase 2 and 3), including IKr, IKs, and
IK1. Thus, the coordinate opening and closing of cardiac ion channels cause arrhythmia susceptibility. Gain of function causes
is responsible for cardiac excitability. prolongation of action potentials, whereas loss-of-func-
tion mutations likely shorten action potentials and slow
conduction velocity.mains located between S5 and S6. The a subunit can
form functional channels, but accessory b subunits have
also been identified that alter some biophysical proper- KVLQT1 and minK Coassemble to Form Cardiac
IKs Potassium Channelsties of the channel. Mutational analyses have revealed
14 distinct mutations of SCN5A associated with long KVLQT1 is located on chromosome 11p5.5 (Keating et
al., 1991) in a region associated with Beckwith-Weide-QT syndrome (Splawski et al., 2000).
Based on the location of these mutations and the mann syndrome (Lee et al., 1997). Northern analyses
indicate that KVLQT1 is expressed in the heart, placenta,physiology of the disease, it was hypothesized that gain-
of-function mutations in SCN5A would cause long QT lung, kidney (Wang et al., 1996), inner ear and pancreas,
with greatest expression in the pancreas (Yang et al.,syndrome. Normally, cardiac sodium channels open
briefly in response to membrane depolarization. The 1997). KVLQT1 and other genes in the region are im-
printed, with paternal silencing in most tissues. How-channel is then inactivated and remains closed for the
remainder of the action potential. Sodium channel inacti- ever, KVLQT1 is not imprinted in the heart (Lee et al.,
1997). Two homologs of KVLQT1 (KCNQ2, KCNQ3) havevation is mediated by an intracellular domain located
between DIII and DIV. This domain is referred to as the been identified in the brain and associated with benign
familial neonatal seizures, an inherited form of epilepsyinactivation gate and is thought to physically block the
inner mouth of the channel pore. Several SCN5A muta- (Charlier et al., 1998; Singh et al., 1998; Yang et al.,
1998).tions associated with long QT syndrome were identified
in this region. Physiologic characterization of one of The cDNA-predicted amino acid sequence of KVLQT1
suggests that this gene encodes voltage-gated potas-these mutants (D KPQ) led to the discovery that the
mutations destabilized the inactivation gate (Bennett et sium channel a subunits. It has six putative membrane-
spanning domains, S1–S6, including a voltage sensoral., 1995). Activation of these mutant sodium channels
is normal and the rate of inactivation appears slightly (S4) and a potassium channel pore signature sequence
between S5 and S6 (Figure 2). The intracellular N-termi-faster than normal, but mutant channels can also reopen
during the plateau phase of the action potential. The nal segment of KVLQT1 is short. Mutational analyses
have revealed 85 mutations of KVLQT1 coding se-net effect is a small, maintained depolarizing current
that is modeled to be present during the plateau phase quences, representing z40% of known arrhythmia-
associated mutations discovered to date. Most of theseof the action potential (Bennett et al., 1995; Dumaine et
al., 1996). This lengthens action potential duration. Other mutations are missense mutations located in membrane
spanning regions as well as the pore region.long QT syndrome-associated mutations of SCN5A had
slightly different effects on mutant channels at the single Heterologous expression of KVLQT1 in mammalian
cells and Xenopus oocytes revealed that this gene en-channel level, but all led to maintained depolarizing cur-
rents and action potential prolongation, setting up a codes a subunits that form voltage-gated potassium
channels (Barhanin et al., 1996; Sanguinetti et al.,substrate for arrhythmia.
SCN5A mutations also cause familial ventricular fibril- 1996b). However, the biophysical properties of the in-
duced current were unlike any potassium current identi-lation (Table 1). In some cases, these mutations are
clearly loss-of-function. For example, a nonsense muta- fied in cardiac myocytes. This observation led to the
hypothesis that KVLQT1 subunits might assemble withtion of SCN5A has been associated with ventricular fi-
brillation in an otherwise healthy individual who has no subunits encoded by another gene to form a cardiac
potassium channel.obvious electrocardiographic abnormalities (Chen et al.,
1998). Other mutations that have been associated with minK, which is located on chromosome 21, received
this name because it was thought to encode the minimalthis disorder are less clear-cut in terms of their physio-
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potassium channel subunit. Only 129 amino acids long, and mutant subunits have reduced or no function. The
this predicted amino acid sequence has room for one net effect is a greater than 50% reduction in channel
putative membrane-spanning domain. It contains no po- function, a dominant-negative effect. The severity of the
tassium channel pore signature sequence and no puta- dominant-negative effect varies considerably depend-
tive voltage-sensing domain. Although it is not a com- ing on the site and type of mutation. In some cases, the
mon cause of arrhythmia susceptibility, mutations in this dominant-negative effect is relatively small whereas in
gene have been associated with long QT syndrome and others the effect is complete, leading to marked reduc-
homozygous mutations cause Jervell and Lange-Niel- tion of IKs even in heterozygotes. Missense mutations in
son syndrome (Schulze-Bahr et al., 1997; Splawski et the pore sequences seem to be particularly potent. The
al., 1997a, 1997b). Ten arrhythmia-associated mutations severity of the dominant-negative effect likely has an
of minK have been identified. This represents z5% of impact on the severity of arrhythmia susceptibility in
long QT syndrome mutations identified to date. individuals. However, there are many factors that affect
minK was initially cloned by functional expression in arrhythmia susceptibility, and extensive phenotypic vari-
Xenopus oocytes (Takumi et al., 1988). The biophysical ability can be seen between family members carrying
properties of the current elicited by expression of minK the same primary genetic mutations.
were similar to cardiac IKs, one of the main currents KVLQT1 and minK are both expressed in the inner ear.
responsible for termination of the cardiac action poten- Here, the channel functions to produce a potassium-rich
tial. Thus, investigators concluded that minK encoded fluid known as endolymph that bathes the organ of Corti,
subunits that formed cardiac IKs channels. However, the cochlear organ responsible for hearing. Individuals
there were several problems with this hypothesis. First, with Jervell and Lange-Nielsen syndrome have homozy-
as noted above, the structure of minK was unusual. gous mutations of KVLQT1 or minK, and therefore have
The typical voltage-gated potassium channel has six no functional IKs channels. As noted above, these individ-
membrane-spanning domains and four subunits are re- uals have severe arrhythmia susceptibility and congeni-
quired for assembly and formation of functional chan- tal neural deafness. The mechanism of deafness in these
nels. Because minK was small and only had one putative individuals is that the lack of IKs leads to inadequate
membrane-spanning domain, investigators hypothesized endolymph production and deterioration of the organ
that many subunits might assemble to form functional of Corti (Vetter et al., 1996). Deafness can also result
channels. Some experiments, however, suggest that from mutations in KCNQ4, a gene that encodes a homo-
only two units were required for expression (Wang and log of KVLQT1 that is highly expressed within sensory
Goldstein, 1995; Tai et al., 1997). Second, physiologic outer hair cells of the inner ear (Kubisch et al., 1999).
studies indicated that expression of minK in mammalian
cells failed to induce a current. Finally, expression of HERG Encodes the a Subunit of Cardiac IKrincreasing amounts of minK in Xenopus oocytes did not Potassium Channels
lead to increasing current, indicating saturability. HERG, located on chromosome 7q35-q36, is expressed
It is now clear that minK b subunits assemble with primarily in the heart (Curran et al., 1995). HERG was
KVLQT a subunits to form cardiac IKs channels (Barhanin originally identified from a human hippocampal cDNA
et al., 1996; Sanguinetti et al., 1996b). Heterologous ex-
library (Warmke and Ganetzky, 1994) and is also ex-
pression of minK alone in mammalian cells produced
pressed in neural crest–derived neurons and microglia.
no current. By contrast, heterologous expression of
Ninety-four distinct mutations of HERG have been iden-KVLQT1 and minK together led to a large potassium
tified (Splawski et al., 2000). These represent 45% ofcurrent with the biophysical properties of cardiac IKs. the total number of long QT syndrome mutations foundAlthough the stoichiometry of coassembly is not yet
to date.known, it is likely that four KVLQT1 a subunits assemble
Based on its predicted amino acid sequence, HERGwith four minK b subunits to form these channels.
was thought to encode a typical voltage-gated potas-How is it that minK alone can be functionally ex-
sium channel a subunit with 6 membrane-spanning do-pressed in Xenopus oocytes? The explanation is that a
mains (S1–S6), a voltage sensor (S4), and a K1-selectivehomolog of KVLQT1, XKVLQT1, is constitutively ex-
pore between S5 and S6. HERG has a large intracellularpressed in Xenopus oocytes, but at a relatively low level
C-terminal region containing a cyclic nucleotide binding(Sanguinetti et al., 1996b). This homolog can interact
domain. HERG also has a large N-terminal domain, thewith minK, forming an IKs-like channel.
first 135 amino acids of which are highly conserved withAt least two molecular mechanisms account for re-
comparable domains in related channels. The structureduced KVLQT1 function in the long QT syndrome (Woll-
of the N-terminal domain has been solved and has struc-nik et al., 1997; Wang et al., 1999). In the first, disease-
tural similarity to PAS (Per-Arnt-Sim) domains (Moraisassociated intragenic deletions of one KVLQT1 allele
et al., 1998). Proteins with PAS domains are frequentlyresult in syntheses of abnormal subunits that do not
involved in signal transduction. Analysis of long QT syn-assemble with normal subunits. As a result, only normal
drome-associated missense mutations located in thesubunits form the functional tetrameric channels. This
PAS domain of HERG revealed that this region is impor-loss-of-function mechanism results in a 50% reduction
tant in mediating the slow rate of channel deactivationin the number of functional channels. In the second
(Chen et al., 1999).mechanism, missense mutations result in synthesis of
Expression of HERG in heterologous systems led toKVLQT1 subunits with subtle structural abnormalities.
the discovery that this gene encodes a subunits thatMany of these subunits can assemble with normal sub-
form cardiac IKr potassium channels, the second of theunits, forming heterotetramers with varying stoichiome-
try. Channels formed from the coassembly of normal two channels primarily responsible for termination of
Review
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the plateau phase of the action potential (Sanguinetti of the contractile apparatus. The four mutations identi-
fied in RyR2 to date are missense mutations. The func-et al., 1995; Trudeau et al., 1995). One of the unusual
biophysical properties of IKr channels that was repro- tional consequences of these mutations are not yet
known. A likely possibility, however, is episodic, stress-duced by HERG in Xenopus oocytes is the bell-shaped
current–voltage relationship, a rectification caused by induced Ca21 overload in cardiac myocytes, leading to
a substrate for arrhythmia.C-type inactivation (Smith et al., 1996). This property
accounts for the relative importance of IKr during phase In summary, all known arrhythmia susceptibility genes
encode cardiac ion channels. SCN5A encodes sodium3 of the cardiac action potential. During repolarization
of the action potential, HERG channels rapidly recover channels that are responsible for initiating cardiac action
potentials. HERG encodes a subunits that assemblefrom inactivation into the open state. This results in an
increase in the magnitude of IKr during the first half of with MiRP1 b subunits to form cardiac IKr potassium
channels, whereas KVLQT1 assembles with minK to formphase 3 repolarization despite a decrease in the electro-
chemical driving force for outward flux of K1 (Spector, cardiac IKs potassium channels. IKr and IKs are responsible
for termination of the plateau phase and contribute to1996).
Although many of the biophysical properties of HERG final repolarization of the cardiac action potential. RyR2
encodes the ryanodine receptor/calcium release chan-current in heterologous systems were nearly identical
to cardiac IKr, two properties were out of line (Sanguinetti nel crucial for excitation–contraction coupling. Muta-
tions of SCN5A associated with long QT syndrome de-et al., 1995; Abbott et al., 1999). First, although deactiva-
tion of cardiac IKr was relatively slow, deactivation of stabilize the channel inactivation gate, resulting in
repetitive reopening of mutant channels and abnormalHERG channels was much slower. Second, the kinetics
and voltage dependence of IKr block by methanesulfo- depolarizing sodium current during the plateau phase
of the action potential. Thus, gain-of-function mutationsnanilide drugs were different than HERG channels. This
problem led to the hypothesis that HERG, like KVLQT1, of the cardiac sodium channel cause long QT syndrome.
By contrast, loss-of-function mutations of the cardiacmight assemble with an unknown b subunit to form
cardiac IKr channels. sodium channel cause idiopathic ventricular fibrillation
with or without baseline conduction abnormalities. Mu-MiRP1, or minK-related protein 1, is located on chro-
mosome 21, just 70 kb from minK (Abbott et al., 1999). tations of KVLQT1, HERG, minK, and MiRP1 cause a
loss of function, often with a dominant-negative effectThe two genes have significant homology at the DNA
and amino acid level and likely resulted from a recent that leads to a reduction in repolarizing current. RyR2
mutations probably lead to abnormal intracellular cal-duplication. Missense mutations of MiRP1 have been
associated with long QT syndrome, indicating that it cium metabolism. Taken together, these studies demon-
strate that mutations of cardiac ion channels cause ar-is an arrhythmia-susceptibility gene. When MiRP1 was
expressed with HERG in heterologous systems, the bio- rhythmia susceptibility through multiple molecular
mechanisms.physical and pharmacologic properties of the resultant
current were nearly identical to IKr in cardiac myocytes
(Abbott et al., 1999). Thus, HERG a subunits assemble Reentry, a Fundamental Mechanism of Arrhythmia
with MiRP1 b subunits to form cardiac IKr channels. Together with previous physiologic studies, recent genetic
Many HERG mutations cluster around the membrane- advances provide a picture of cardiac arrhythmias at the
spanning domains and the pore region. Some of these molecular, cellular, and organ levels. Gain-of-function mu-
mutations, such as early nonsense mutations, have a tations of cardiac sodium channels and loss-of-function
pure loss-of-function effect. Oftentimes the encoded mutations of potassium channels delay myocyte repo-
mutant proteins misfold and are rapidly degraded (Zhou larization. Loss-of-function mutations of sodium chan-
et al., 1998), leading to a dominant-negative effect or nels cause conduction abnormalities. Calcium release
haploinsufficiency. However, many long QT syndrome– channel dysfunction probably causes calcium overload.
associated mutations in HERG are missense mutations. These channels are expressed at varying levels in differ-
Because functional IKr channels are comprised of hetero- ent regions of the heart, so the effect of channel dysfunc-
multimers with several HERG subunits, it is possible tion has regional variability. Regional abnormalities of
that many of these mutations have a dominant-negative cardiac repolarization or conduction provide a substrate
affect on channel function. Heterologeous expression for arrhythmia. For example, during a prolonged action
studies indicate that this is a common effect and that potential, myocytes are relatively refractory to electrical
different mutations lead to a spectrum of dominant- excitation by neighboring myocytes. Dispersion of re-
negative suppression of channel function (Roden et al., fractoriness can lead to unidirectional block of a wave
1996; Sanguinetti et al., 1996a; Li et al., 1997). of electrical excitation (Figure 4A). Thus, pockets of cells
that are temporarily unable to conduct the normal flow
of electrical activity in the heart create a substrate forRyR2 Encodes the Calcium Release Channel
RyR2 encodes the ryanodine receptor, a calcium- arrhythmia.
Although unidirectional block can increase the risk ofinduced calcium release channel located in cardiac sar-
coplasmic reticulum. RyR2 channels are activated by arrhythmia, it is not sufficient; a triggering mechanism
is still required. The trigger for arrhythmia in the longCa21 that transiently enters the cell through plasma
membrane–bound L-type calcium channels during de- QT syndrome is believed to be spontaneous secondary
depolarizations that arise during or just following thepolarization of the cardiac myocyte. This Ca21 triggers
the release of Ca21 stored in the sarcoplasmic reticulum plateau phase of action potentials. Secondary depolar-
izations appear as premature, small action potentialsthrough RyR2 channels that in turn initiates activation
Cell
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Figure 5. Unintended Block of HERG Channels by Drugs Is a Com-
mon Mechanism of Acquired Long QT Syndrome
(A) Partial sequence of the S6 transmembrane domain for several
voltage-gated potassium channels. Two unusual structural featuresFigure 4. Unidirectional Block and Reentry, a Fundamental Mecha-
of HERG not shared by other voltage-gated K1 channels are respon-nism of Arrhythmia
sible for common, nonspecific drug interactions. These include a(A) Abnormal cardiac repolarization, conduction, or intracellular cal-
lack of proline residues in the S6 transmembrane domain, and thecium homeostasis can lead to episodic unidirectional block, a sub-
presence of two aromatic residues (Y, F) in this domain that facestrate for arrhythmia. Green arrows represent the normal conduction
the inner cavity of the HERG channel. These aromatic residues formin a bifurcated pathway. Conduction is blocked in an area of refrac-
the drug binding site. (B) The lack of proline residues increases thetory tissue (unidirectional block). If conduction velocity is slowed,
size of the HERG inner cavity, thereby creating a large space forthen reentry through area of refractory tissue can occur (red arrows).
channel–drug interactions in this channel, but not other voltage-(B) Multiple reentrant circuits (multiple curved arrows) is a mecha-
gated potassium (KvX) channels.nism of ventricular fibrillation, the cause of sudden death.
and are mediated by depolarizing inward calcium cur- A common cause of acquired long QT syndrome is a
side effect of numerous common medications of diverserents through L-type calcium channels. This cellular
mechanism predicts that the autonomic nervous system therapeutic and structural classes (Roden, 1998). Exam-
ples of drugs associated with long QT syndrome includecan have a significant impact on arrhythmia suscepti-
bility. Heightened sympathetic tone can substantially terfenadine, cisapride, erythromycin, amiodarone, quini-
dine, phenothiazines, tricyclic antidepressants, and cer-increase spontaneous inward current through L-type
calcium channels, increasing the likelihood that the tain diuretics (the latter mediated through drug-induced
hypokalemia). Most of these medications block HERGspontaneous repolarization will trigger an arrhythmia.
Once triggered, the arrhythmia is maintained by a regen- channels, leading to reduced repolarizing potassium
current and delayed myocellular repolarization. Theseerative circuit of electrical activity around relatively inex-
citable tissue, a phenomenon known as reentry (Figure findings show, therefore, that cardiac ion channel dysfunc-
tion underlies both inherited and acquired arrhythmias.4A). The development of multiple reentrant circuits
within the heart (Figure 4B) causes ventricular fibrillation, The problem of medication-induced long QT syn-
drome is a significant issue to the pharmaceutical indus-the arrhythmia of sudden death.
try and the Food and Drug Administration. Why are
HERG channels so susceptible to nonspecific block byCardiac Ion Channel Dysfunction Underlies
Inherited and Acquired Arrhythmias such a wide variety of medications, and why isn’t ac-
quired long QT syndrome commonly caused by blockAbnormal cardiac repolarization, aberrant conduction,
and arrhythmia susceptibility are most commonly ac- of potassium channels other than HERG that contribute
to cardiac repolarization? The answer to these questionsquired and not primarily genetic. Common acquired
causes of arrhythmia include cardiac ischemia resulting is just beginning to unfold through structural studies
of HERG channels expressed in heterologous systemsfrom the sudden disruption of blood flow to a region of
the heart, structural heart diseases like cardiomyopathy, (Lees-Miller et al., 2000; Mitcheson et al., 2000a) (Figure
5). There are at least two important structural featuresdevelopmental abnormalities of the heart such as ar-
rhythmogenic right ventricular dysplasia, metabolic ab- that account for the unusual susceptibility of HERG
channels to block by diverse drugs. First, the inner cavitynormalities like abnormal serum potassium, calcium or
magnesium levels, and medications. of the HERG channel appears to be much larger than
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any other voltage-gated K1 channel. Almost all voltage- and central neurons. Together, these studies have de-
fined a new class of disease, ion channelopathies (Ash-gated K1 channel a subunits, except HERG, have two
proline residues in the S6 domains that line the inner croft, 2000).
cavity of the channel. These prolines cause a kink in the
S6 and apparently reduce the volume of the inner cavity The Future: Prediction, Prevention, and Treatment
(del Camino et al., 2000). The large inner cavity of HERG of Cardiac Arrhythmias
channels can accommodate and trap large drugs that Despite recent advances, the fields of arrhythmia genet-
other K1 channels can not trap (Mitcheson et al., 2000b). ics, physiology, and therapy are still immature. Major
Second, the S6 domains of HERG channels, but not problems that appear most prominent include the identi-
other voltage-gated K1 channels, have two aromatic fication of all arrhythmia susceptibility genes, the identi-
residues that face into the inner cavity that may bind fication of common genetic variants that contribute to
large aromatic drugs by a p-stacking interaction (Mit- arrhythmia susceptibility in the general population and
cheson et al., 2000a). The two aromatic residues located the implementation of reliable, cost-effective genetic
in each subunit (Tyr652, Phe656) provide a total of eight testing. Genomics and the human genome project have
residues that can form a variable receptor site that can already had a major impact on this field, and that influ-
accommodate drugs from diverse therapeutic and struc- ence will continue to grow in the near future. Early ge-
tural classes. In addition, the binding affinity of drugs netic studies involved tedious methods of positional
is enhanced by inactivation of the HERG channel (Ficker, cloning, because relatively little of the human genome
1998). The net effect of the structural peculiarities of was mapped, genetically or physically, and few human
HERG channels is heightened sensitivity of IKr to struc- genes were defined. The limitations of the technology
turally diverse drugs. Continued structural analysis of available a decade ago added to the difficulties of these
HERG channels coupled with structure–activity relation- experiments. The early genetic linkage analyses, for ex-
ship analysis of medications will help improve our ability ample, required the use of restriction fragment length
to predict drugs that are likely to cause a significant risk polymorphisms (RFLPs) and Southern blots. The situa-
of cardiac arrhythmia. tion is completely different today, and in the very near
Genetic predisposition may play an important role in future genomics and the human genome project will
drug-induced long QT syndrome. For example, less than empower these fields to an even greater extent. Genetic
5% of patients receiving a drug like quinidine have ar- maps will be at the limits of resolution, all human genes
rhythmia as a side effect, irrespective of dose and other will be defined and available in online databases, and
risk factors such as hypokalemia. Recent studies indi- genetic technologies, particularly DNA sequence analy-
cate that drug-induced arrhythmia can be associated sis, will be robust, reliable, and inexpensive. DNA se-
with sporadic mutations (Abbott et al., 1999) and com- quence analysis, in particular, will greatly facilitate the
mon polymorphisms (Sesti et al., 2000) in MiRP1. It is implementation of effective genetic testing for large
likely that mutations or polymorphisms in all of the genes populations using existing information regarding ar-
associated with the inherited forms of long QT syndrome rhythmia susceptibility genes.
will eventually be shown to increase the risk of the ac- Although prospects for future research are promising,
quired form of this disease. at least one significant hurdle remains—ascertainment
and phenotypic characterization of individuals with ar-
rhythmia susceptibility and appropriate controls. TheMultiple Events Are Required to Induce
Cardiac Arrhythmias identification of novel arrhythmia genes and common
arrhythmia susceptibility variants will involve geneticStudies of inherited and acquired arrhythmias have led
us to hypothesize a multi-hit mechanism for this disease. epidemiology—the genotypic characterization of large
numbers of carefully phenotyped individuals. For the mostIt is clear that at least three things have to go wrong
simultaneously for a life-threatening arrhythmia to oc- part, the process of ascertaining and phenotypically char-
acterizing individuals has been slow to change, involvingcur. For example, most individuals carrying one mutant
allele of an arrhythmia susceptibility gene have few, if a great deal of one-on-one effort in a process that is not
easily scalable. Even here, however, new technologyany, arrhythmias. By contrast, individuals carrying two
mutant alleles (e.g., Jervell and Lange-Nielson syn- holds the promise for significant improvement. The in-
ternet revolution has connected populations of individu-drome) have many arrhythmias and usually die during
childhood unless effective treatment is implemented. als separated by large distances to instantaneously and
effortlessly meet and communicate about many sub-That these individuals nevertheless live into early child-
hood, even when untreated, indicates that an additional jects, including disease. Many for- and not-for-profit
organizations have created web sites aimed at unifying,event, such as the introduction of a medication, hypoka-
lemia, or a sinus pause, is required for an arrhythmia. It organizing, empowering, and informing individuals with
virtually every imaginable health concern. By creatingis clear, however, that a genetic mechanism is not a
prerequisite for an arrhythmia. It is known, for example, and working with these websites, investigators may ac-
celerate the rate-limiting step of the human molecularthat arrhythmia can be induced in virtually anyone with
the right combination of drug, hypokalemia, and a long genetic process.
Functional genomics, thus far largely limited to ex-sinus pause.
Arrhythmia genetics and physiology have converged pression and protein–protein interaction studies, will
also have an impact on this field. It is already clearwith a growing body of evidence implicating ion chan-
nels in episodic diseases of excitable cells, including that by examining the expression of arrhythmia genes
in tissues other than the heart, one can hypothesize thedisorders of skeletal muscle, vascular smooth muscle,
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lecular mechanism for an inherited cardiac arrhythmia. Nature 376,existence of pathology in other tissues that were not
683–685.apparent from previous clinical studies. The clinical
Brugada, J., Brugada, R., and Brugada, P. (1997). Right bundleworld tends to focus on the most severe, life-threaten-
branch block, ST segment elevation in leads V1–V3: a marker foring, and obvious phenotypic features of the disorder.
sudden death in patients without demonstrable structural heart dis-
It is hard to ignore congenital deafness and sudden ease. Circulation 96, 1151.
arrhythmic death. However, many of these genes are
Charlier, C., Singh, N.A., Ryan, S.G., Lewis, T.B., Reus, B.E., Leach,
expressed in other tissues and evidence of pathology R.J., and Leppert, M. (1998). A pore mutation in a novel KQT-like
in these tissues is beginning to emerge. KVLQT1, for potassium channel gene in an idiopathic epilepsy family. Nat. Genet.
18, 53–55.example, is expressed in the pancreas and it may be
discovered that mutations in this gene cause a subtle Chen, J., Zou, A., Splawski, I., Keating, M.T., and Sanguinetti, M.C.
(1999). Long QT syndrome-associated mutations in the Per-Arntrisk factor for pancreatitis.
Sim (PAS) domain of HERG potassium channels accelerate channelAs most ion channels are heteromultimers, and may
deactivation. J. Biol. Chem. 274, 10113–10118.be modulated by interaction with signaling molecules,
Chen, Q., Kirsch, G.E., Zhang, D., Brugada, R., Brugada, J., Brugada,databases of protein–protein interactions will also be
P., Potenza, D., Moya, A., Borggrefe, M., Breithardt, G., et al. (1998).
valuable. It is likely, however, that each interaction will Genetic basis and molecular mechanism for idiopathic ventricular
require validation. It is already known, for example, that fibrillation. Nature 392, 293–296.
minK can interact with KVLQT1 and HERG when overex- Compton, S.J., Lux, R.L., Ramsey, M.R., Strelich, K.R., Sanguinetti,
pressed in heterologeous systems (McDonald et al., M.C., Green, L.S., Keating, M.T., and Mason, J.W. (1996). Gene
derived therapy in inherited long QT syndrome: correction of abnor-1997). It is not clear, however, that the interaction of
mal repolarization by potassium. Circulation 94, 1018–1022.minK with HERG has physiologic relevance (Abbott et
Curran, M.E., Splawski, I., Timothy, K.W., Vincent, G.M., Green, E.D.,al., 1999). Nevertheless, broad functional databases will
and Keating, M.T. (1995). A molecular basis for cardiac arrhythmia:have great value, at least as a starting point.
HERG mutations cause long QT syndrome. Cell 80, 795–803.Recent molecular and cellular studies have important
del Camino, D., Holmgren, M., Liu, Y., and Yellen, G. (2000). Blockerimplications for the prevention and treatment of arrhyth-
protection in the pore of a voltage-gated K1 channel and its struc-mias. Identification and characterization of arrhythmia
tural implications. Nature 403, 321–325.
susceptibility genes provide the foundation for preven-
Duggal, P., Vesely, M.R., Wattanasirichaigoon, D., Villafane, J.,
tion thorough genetic testing. The observation that Kaushik, V., and Beggs, A.H. (1998). Mutation of the gene for IsK
HERG channel function is paradoxically sensitive to ex- associated with both Jervell and Lange-Nielsen and Romano-Ward
tracellular potassium concentrations highlights the im- forms of Long-QT syndrome. Circulation 97, 142–146.
portance of maintaining normal electrolyte levels and Dumaine, R., Wang, Q., Keating, M.T., Hartmann, H.A., Schwartz,
P.J., Brown, A.M., and Kirsch, G.E. (1996). Multiple mechanisms ofprovides a new strategy for treatment (Compton et al.,
sodium channel-linked long QT syndrome. Circ. Res. 78, 914–924.1996). The most important therapeutic consequence of
Ficker, E. (1998). Molecular determinants of dofetilide block of HERGthis work, however, is the message it delivers to physi-
K1 channels. Circ. Res. 82, 386–395.cians and to the pharmaceutical industry: the observa-
Gellens, M., George, A., Chen, L., Chahine, M., Horn, R., Barchi, R.,tions that gain- and loss-of-function mutations of the
and Kallen, R. (1992). Primary structure and functional expressioncardiac sodium channel both cause arrhythmia suscep-
of the human cardiac tetrodotoxin-insensitive voltage-dependent
tibility indicate that drugs that modulate cardiac ion sodium channel. Proc. Natl. Acad. Sci. USA 89, 554–558.
channel function may reduce the risk of one type of
Hoorntje, T., Alders, M., van Tintelen, P., van der Lip, K., Sreeram,
arrhythmia but increase the risk of another. Thus, N., van der Wal, A., Mannens, M., and Wilde, A. (1999). Homozygous
chronic use of cardiac ion channel blockers can be dan- premature truncation of the HERG protein: the human HERG knock-
out. Circulation 100, 1264–1267.gerous. The future of arrhythmia therapy may be devices
that measure cardiac conduction and repolarization, de- Jervell, A., and Lange-Nielsen, F. (1957). Congenital deaf-mutism,
functional heart disease with prolongation of the QT interval, andliver appropriate antiarrhythmic drugs when needed,
sudden death. Am. Heart J. 54, 59–68.and provide a safety net in the form of automatic internal
Jiang, C., Atkinson, D., Towbin, J., Splawski, I., Lehmann, M., Li, H.,defibrillation (Moss, 1997).
Timothy, K., Taggart, R., Schwartz, P., Vincent, G., et al. (1994). Two
long QT syndrome loci map to chromosome 3 and 7 with evidenceAcknowledgments
for further heterogeneity. Nat. Genet. 8, 141–147.
Kannel, W., Cupples, A., and D’Agostino, R. (1987). Sudden deathWe thank I. Splawski for advice, D. Atkinson for help preparing
risk in overt coronary heart diseases: the Framingham study. Am.figures, and L. Morelli for assistance preparing the manuscript.
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